Lucira Health, Inc (LHDX)

Etorro trading 970x250

About Lucira Health, Inc

Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops testing platform that provides molecular testing services. The company offers LUCIRA COVID- 19 All- In- One Test Kit, that provides COVID- 19 result; and develops influenza A and B viruses test kits. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was founded in 2013 and is headquartered in Emeryville, California. Address: 1412 62nd Street, EmeryVille, CA, United States, 94608

Lucira Health, Inc News and around…

Latest news about Lucira Health, Inc (LHDX) common stock and company :

73 Biggest Movers From Yesterday
17 May, 2022 FinancialContent

Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on ...

12 Health Care Stocks Moving In Monday's Intraday Session
16 May, 2022 FinancialContent

Gainers Harpoon Therapeutics (NASDAQ:HARP) shares increased by 38.0% to $2.76 during Monday's regular session. As of ...

41 Stocks Moving In Monday's Mid-Day Session
16 May, 2022 FinancialContent

Gainers Data Storage Corporation (NASDAQ: DTST) shares jumped 51.1% to $3.4750 after the company reported better-than-expected Q1 ...

Lucira Health, Inc. (LHDX) Q1 2022 Earnings Call Transcript
13 May, 2022 FinancialContent

LHDX earnings call for the period ending March 31, 2022.

Lucira Health: Q1 Earnings Insights
12 May, 2022 FinancialContent

Lucira Health (NASDAQ:LHDX) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know ...

Lucira Health Announces First Quarter 2022 Results and Business Update
12 May, 2022 Yahoo! Finance

EMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) (“Lucira Health,” “Lucira” or the “Company”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tests, today reported financial results and provided business updates for the first quarter ended March 31, 2022. Recent Highlights Achieved net revenue of $90.5 million for the first quarter of 2022, equivalent to 97% of fiscal year 20

Biden mourns one million American lives lost to pandemic, orders flags to fly at half-mast to honor the dead
12 May, 2022 FinancialContent

President Joe Biden mourned the one million American lives lost to the pandemic on Thursday, and said flags will be flown at half-staff at the White House and all public buildings, grounds, military posts and naval vessels until sunset on May 16 to honor the dead.

Lucira Health files for FDA authorization of first COVID-19 & flu at-home molecular test
12 May, 2022 Yahoo! Finance

Lucira Health Inc. said Thursday it has filed for Food and Drug Administration authorization for its first-of-its-kind COVID-19 & flu at-home molecular test. The medical tech company, which went public in February of 2021, specializes in single-use test kits for respiratory diseases. "The request is for prescription at-home use of the PCR-quality test for those with suspected COVID-19 or Influenza," the company said in a statement. The company is hoping to get authorized ahead of the fall and wi

Lucira Files for Authorization of First-of-its-Kind COVID-19 & Flu At-Home Molecular Test
12 May, 2022 Yahoo! Finance

This first ever at-home COVID-19 and flu test is designed to allow individuals to differentiate between the infections and seek appropriate treatment within 30 minutes from homeEMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of innovative infectious disease tests, announced today that it has submitted a request to the U.S. Food and Drug Administrati

Analysts Are Optimistic We'll See A Profit From Lucira Health, Inc. (NASDAQ:LHDX)
09 May, 2022 Yahoo! Finance

Lucira Health, Inc. ( NASDAQ:LHDX ) is possibly approaching a major achievement in its business, so we would like to...

Lucira Receives CE Mark for both COVID-19 & Flu and COVID-19 Molecular Tests
09 May, 2022 Yahoo! Finance

Lucira COVID-19 Test Packaging Lucira COVID-19 Test Packaging Lucira COVID-19 & Flu Test Packaging Lucira COVID-19 & Flu Test Packaging EMERYVILLE, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of innovative infectious disease tests, announced that both its COVID-19 & Flu and COVID-19 molecular tests have received CE Mark for professional use, clearing both t

Lucira Health to Participate in Bank of America 2022 Healthcare Conference
04 May, 2022 Yahoo! Finance

EMERYVILLE, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will participate in the Bank of America 2022 Healthcare Conference on May 11th, 2022, at 11:00pm ET. Lucira’s management is scheduled to present at the Bank of America 2022 Healthcare Conference on May 11th, 2022, at 11:00

Lucira Health to Announce First Quarter 2022 Financial Results
28 Apr, 2022 Yahoo! Finance

EMERYVILLE, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will report first quarter 2022 financial results on Thursday, May 12, 2022. Lucira’s management will host a conference call and webcast at 1:30 p.m. PT / 4:30 p.m. ET that day to discuss the financial results and provide

Covid test maker makes play for combo test with flu
25 Apr, 2022 Yahoo! Finance

"The mask mandates going away for airlines are a perfect example — it's less and less a situation where you have to do certain things. It's coming back to normal — you test because you choose to or because you're sick."

LabCorp (LH) to Report Q1 Earnings: What's in the Cards?
22 Apr, 2022 Yahoo! Finance

Robust base business growth and notable launches are likely to have contributed to LabCorp's (LH) Q1 performance.

Zacks.com featured highlights Kontoor, The Buckle, Lovesac, BRP and Lucira Health
22 Apr, 2022 Yahoo! Finance

Kontoor, The Buckle, Lovesac, BRP and Lucira Health have been highlighted in this Screen of The Week article.

LUCIRA HEALTH AND USA BOXING ANNOUNCE EXCLUSIVE PARTNERSHIP FOR THE 2022 SEASON
21 Apr, 2022 Yahoo! Finance

Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focusing on the development and commercialization of transformative and innovative infectious disease tests, announces its first-ever partnership with USA Boxing as the official COVID-19 test provider for the 2022 season. Lucira will provide its Check-It COVID-19 test kits to USA Boxing athletes, coaches, and staff.

Grab Market Momentum With 5 Top Rising P/E Stocks
21 Apr, 2022 Yahoo! Finance

Forget undervalued stocks, play these top-ranked stocks (BKE, LHDX, DOOO, LOVE, KTB) with rising P/E.

Lucira Health Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 Apr, 2022 Yahoo! Finance

EMERYVILLE, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that on April 6, 2022, the Board of Directors of Lucira granted inducement awards consisting of 20,825 restricted stock units (“RSUs”) to three new employees under Lucira’s 2022 Inducement Plan. The Board of Directors approved the awards as an induceme

51 Biggest Movers From Yesterday
06 Apr, 2022 FinancialContent

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced ...

30 Stocks Moving In Tuesday's Mid-Day Session
05 Apr, 2022 FinancialContent

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 139% to $5.40 after the company announced that two of its designed ...

Looking for a Growth Stock? Why It is Time to Focus on Lucira Health (LHDX)
05 Apr, 2022 Yahoo! Finance

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Lucira Health (LHDX).

Lucira Donates Rapid Molecular At-Home COVID-19 Test Kits to Protect the Safety of Tonga Red Cross Society Workers
31 Mar, 2022 Yahoo! Finance

Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tests, donated 2,000 Lucira™ Check-It COVID-19 tests, a rapid at-home test with PCR-quality accuracy, for Tonga humanitarian efforts after the eruption of the Hunga Tonga-Hunga Ha'apai volcano in January 2022. The Tonga Red Cross Society was immediately on the scene of the disaster providing relief to l

Lucira Health's COVID-19 & Flu At-Home Molecular Test Shows Positive Clinical Study Results
29 Mar, 2022 Yahoo! Finance

Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tests, announced that preliminary clinical study results for its COVID-19 & Flu test demonstrated similar sensitivity and specificity to highly sensitive lab-based PCR assays for COVID-19, Flu A, and Flu B.

Lucira Health's PCR-Quality At-Home COVID-19 Test Now Available Direct to Consumers in Canada
24 Mar, 2022 Yahoo! Finance

Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tests, announced that its Lucira™ Check-It COVID-19 test can now be purchased directly by Canadian consumers, businesses, and healthcare providers, available at www.checkit.lucirahealth.ca.

Lucira Health Terminates COVID-19 Test-Related Patent Agreement With Eiken Chemical
15 Mar, 2022 FinancialContent

According to an SEC filing,Lucira Health Inc(NASDAQ: LHDX) has terminated a Patent License withEiken Chemical Co ...

Lucira Health, Inc. (LHDX) Q4 2021 Earnings Call Transcript
11 Mar, 2022 FinancialContent

LHDX earnings call for the period ending December 31, 2021.

Benzinga's After-Hours Movers & News: DocuSign, Clearside Biomedical And More
10 Mar, 2022 FinancialContent

Benzinga's “After-Hours Movers & News” highlights the biggest movers of the day. The information on the price action ...

Earnings Scheduled For March 10, 2022
10 Mar, 2022 FinancialContent

Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share ...

12 Health Care Stocks Moving In Wednesday's After-Market Session
09 Mar, 2022 FinancialContent

Gainers Immutep (NASDAQ:IMMP) stock rose 18.1% to $3.39 during Wednesday's after-market session. Today's trading volume for this ...

Lucira Health, Inc (LHDX) is a NASDAQ Common Stock listed in , ,

970x250